REGEN BIOPHARMA, INC. Unrealized Gain (Loss) on Securities
REGEN BIOPHARMA, INC. (RGBP) reported Unrealized Gain (Loss) on Securities of -$128.00 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2018-12-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnSecurities · last filed 2018-12-27
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for the quarter ending 2018-09-30 was -$90.40K.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for the quarter ending 2018-06-30 was -$18.40K.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for the quarter ending 2018-03-31 was -$19.20K.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for the quarter ending 2017-12-31 was $0.00.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for fiscal 2018 was -$128.00K.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for fiscal 2017 was -$40.00K.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for fiscal 2016 was -$46.40K.
- REGEN BIOPHARMA, INC. unrealized gain (loss) on securities for fiscal 2015 was -$33.60K.
| Period end | Unrealized Gain (Loss) on Securities 3 month | Unrealized Gain (Loss) on Securities 6 month | Unrealized Gain (Loss) on Securities 9 month | Unrealized Gain (Loss) on Securities 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$90.40K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-27 | -$108.80K derived: sum of 2 quarters · filed 2018-12-27 | -$128.00K derived: sum of 3 quarters · filed 2018-12-27 | -$128.00K 10-K · filed 2018-12-27 |
| 2018-06-30 | -$18.40K 10-Q · filed 2018-08-06 | -$37.60K derived: sum of 2 quarters · filed 2018-08-06 | -$37.60K 10-Q · filed 2018-08-06 | -$69.60K derived: sum of 4 quarters · filed 2018-12-27 |
| 2018-03-31 | -$19.20K 10-Q · filed 2018-05-14 | -$19.20K 10-Q · filed 2018-05-14 | -$51.20K derived: sum of 3 quarters · filed 2018-12-27 | -$59.20K derived: sum of 4 quarters · filed 2018-12-27 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-12-27 | -$32.00K derived: sum of 2 quarters · filed 2018-12-27 | -$40.00K derived: sum of 3 quarters · filed 2018-12-27 | |
| 2017-09-30 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-27 | -$40.00K derived: sum of 2 quarters · filed 2018-12-27 | -$40.00K 10-K · filed 2018-12-27 | |
| 2017-06-30 | -$8.00K 10-Q · filed 2018-08-06 | -$8.00K 10-Q · filed 2018-08-06 | ||
| 2016-09-30 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-21 | $55.20K derived: sum of 2 quarters · filed 2016-12-21 | -$8.00K derived: sum of 3 quarters · filed 2016-12-21 | -$46.40K 10-K · filed 2016-12-21 |
| 2016-06-30 | $23.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-01 | -$40.00K derived: sum of 2 quarters · filed 2016-08-01 | -$78.40K 10-Q · filed 2016-08-01 | -$112.00K derived: sum of 4 quarters · filed 2017-01-27 |
| 2016-03-31 | -$63.20K 10-Q · filed 2016-04-29 | -$101.60K 10-Q · filed 2016-04-29 | -$135.20K derived: sum of 3 quarters · filed 2017-01-27 | -$135.20K derived: sum of 4 quarters · filed 2017-01-27 |
| 2015-12-31 | -$38.40K 10-Q · filed 2017-01-27 | -$72.00K derived: sum of 2 quarters · filed 2017-01-27 | -$72.00K derived: sum of 3 quarters · filed 2017-01-27 | |
| 2015-09-30 | -$33.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-21 | -$33.60K derived: sum of 2 quarters · filed 2016-12-21 | -$33.60K 10-K · filed 2016-12-21 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-01 | $0.00 10-Q · filed 2016-08-01 | ||
| 2014-12-31 | $0.00 10-Q/A · filed 2017-04-28 |